Vacseal® II Vacuum Leak Sealant, Clear

Distributor: SPI Supplies / Structure Probe Inc.
206 Garfield Avenue
West Chester, PA 19380
Phone: 610-436-5400; 1-800-242-4774
Fax: 610-436-5755
Email: sales @2spi.com
SPI Catalog #’s: 05106C-AB, 05100C-AB, 05101C-AB, 05102C-AB

Safety Data Sheet

Section 1: Identification of the Substance/Mixture and of the Company/Undertaking

1.1 Product identifier
Product Name•

Synonyms• Vacseal II Vacuum Leak Sealant, clear

Vacseal® II High Vacuum Leak Sealant

1.2 Relevant identified uses of the substance or mixture.
Relevant identified use(s)• Primarily used for sealing leaks in high and ultra high vacuum systems.

1.3 Details of the supplier of the safety data sheet
Manufacturer• Space Environment Labs - Vacseal Inc.
4949 N. Broadway
Boulder Colorado 80304
www.vacseal.net• 1-303-443-4090

1.4 Emergency telephone number• 1-(800)-424-9300 - Chemtrec• 1-(703)-741-5970 - Worldwide

Section 2: Hazards Identification
EU/EEC

According to: Regulation (EC) No 1272/2008 (CLP)/REACH 1907/2006 [amended by 2015/830]

2.1 Classification of the substance or mixture
CLP• Flammable Liquids 2 - H225
Acute Toxicity Dermal 4 - H312
Acute Toxicity Inhalation 4 - H332
Specific Target Organ Toxicity Repeated Exposure 2 - H373

2.2 Label Elements
CLP

DANGER

Hazard statements • H225 - Flammable liquid and vapor

H304 - May be fatal if swallowed and enters airways
H312 - Harmful in contact with skin

Revision Date: March 2020
Page 1 of 13

Format: EU CLP/REACH Language: English (US)EU CLP, OSHA HCS 2012

Vacseal® II Vacuum Leak Sealant, Clear

H332 - Harmful if inhaled
H373 - May cause damage to organs through prolonged or repeated exposure.

Precautionary statements
Prevention • P233 - Keep container tightly closed.
P235 - Keep cool.
P240 - Ground and/or bond container and receiving equipment.
P241 - Use explosion-proof electrical/ventilating/lighting/equipment.
P242 - Use only non-sparking tools.
P243 - Take precautionary measures against static discharge.
P260 - Do not breathe mist, vapours and/or spray.
P271 - Use only outdoors or in a well-ventilated area.
P280 - Wear protective gloves/protective clothing/eye protection/face protection.
Response • P370+P378 - In case of fire: Use appropriate media for extinction.
P304+P340 - IF INHALED: Remove victim to fresh air and keep at rest in a position
comfortable for breathing.
P312 - Call a POISON CENTER or doctor/physician if you feel unwell.
P303+P361+P353 - IF ON SKIN (or hair): Take off immediately all contaminatedclothing. Rinse skin with water/shower.
P322 - Specific measures, see supplemental first aid information.
P363 - Wash contaminated clothing before reuse.
P301+P310 - IF SWALLOWED: Immediately call a POISON CENTER or
doctor/physician.
P310 - Immediately call a POISON CENTER or doctor/physician.
P331 - Do NOT induce vomiting.
P314 - Get medical advice/attention if you feel unwell.
Storage/Disposal • P403+P235 - Store in a well-ventilated place. Keep cool.
P405 - Store locked up.
P501 - Dispose of content and/or container in accordance with local, regional,
national, and/or international regulations.
Supplemental information • This product consists of an ingredient of unknown toxicity at 15-25 percent via dermal
and inhalation route.

2.3 Other Hazards
CLP• According to Regulation (EC) No. 1272/2008 (CLP) this material is consideredhazardous.

United States (US)
According to: OSHA 29 CFR 1910.1200 HCS

2.1 Classification of the substance or mixture
OSHA HCS 2012

• Flammable Liquids 3
Skin Irritation 2
Eye Irritation 2
Acute Toxicity Inhalation 4
Specific Target Organ Toxicity Single Exposure 3
Respiratory Tract Irritation 3
Germ Cell Mutagenicity 1B
Carcinogenicity 2
Reproductive Toxicity 1B
Specific Target Organ Toxicity Repeated Exposure 2

2.2 Label elements
OSHA HCS 2012

DANGER

Revision Date: March 2020
Page 2 of 13

Format: EU CLP/REACH Language: English (US)EU CLP, OSHA HCS 2012

Vacseal® II Vacuum Leak Sealant, Clear

Hazard statements • Flammable liquid and vapor

May be fatal if swallowed and enters airways
Causes skin irritation
Causes serious eye irritation
Harmful if inhaled
May cause respiratory irritation
May cause drowsiness or dizziness
May cause genetic defects.
Suspected of causing cancer.
May damage fertility or the unborn child.
May cause damage to organs through prolonged or repeated exposure.

Precautionary statements
Prevention • Obtain special instructions before use.
Do not handle until all safety precautions have been read and understood.
Keep away from heat, sparks, open flames and/or hot surfaces. - No smoking.
Keep container tightly closed.
Keep cool.
Ground and/or bond container and receiving equipment.
Use explosion-proof electrical/ventilating/lighting/equipment.
Use only non-sparking tools.
Take precautionary measures against static discharge.
Do not breathe mist, vapours and/or spray.
Wash thoroughly after handling.
Use only outdoors or in a well-ventilated area.
Wear protective gloves/protective clothing/eye protection/face protection.

Response • .IF INHALED: Remove person to fresh air and keep comfortable for breathing.
Call a POISON CENTER or doctor/physician if you feel unwell.
If on skin: Wash with plenty of soap and water.
Specific treatment, see supplemental first aid information.
Take off contaminated clothing and wash before reuse.
If skin irritation occurs: Get medical advice/attention.
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lensContinue rinsing.
If eye irritation persists: Get medical advice/attention.
IF SWALLOWED: Immediately call a POISON CENTER/doctor .
Do NOT induce vomiting.
IF exposed or concerned: Get medical advice/attention.
Get medical advice/attention if you feel unwell.
Storage/Disposal • Store in a well-ventilated place. Keep container tightly closed.
Keep cool.
Store locked up.
Dispose of content and/or container in accordance with local, regional, national, and/orinternational regulations.
Supplemental information • 15-25 percent of this product consists of an ingredient of unknown toxicity.

2.3 Other hazards
OSHA HCS 2012

• Under United States Regulations (29 CFR 1910.1200 - Hazard Communication
Standard), this product is considered hazardous.

Section 3 - Composition/Information on Ingredients
3.1 Substances• Material does not meet the criteria of a substance.

3.2 Mixtures
Revision Date: March 2020
Page 3 of 13

Format: EU CLP/REACH Language: English (US)EU CLP, OSHA HCS 2012

Vacseal® II Vacuum Leak Sealant, Clear

Composition
ChemicalName

Identifiers%

LD50/LC50

Classifications According to Regulation/Directive

Comments

30%
TO
50%

Ingestion/Oral-Rat
LD50 • 4300 mg/kg
Inhalation-Rat
LC50 • 5000 ppm 4
Hour(s)Skin-Rabbit LD50 •>1700 mg/kg

EU CLP: Annex VI, Table 3.1: Flam. Liq. 3, H226; AcuteTox. 4, H312; Acute Tox. 4, H332; Skin Irrit. 2, H315
OSHA HCS 2012: Flam. Liq. 3; Acute Tox. 4 (Inhl); Skin
Irrit. 2; Eye Irrit. 2; Repr. 1B (Inhl); STOT SE 3: Narc.;
STOT SE 3: Resp. Irrit.

NDA

NDA

XyleneCAS:1330-20-7
EC
Number:215535-7
EU Index:601022-00-9

Ethylbenzene

CAS:100-41-4
EC
Number:202849-4
EU Index:601023-00-4

10%
TO
30%

Ingestion/Oral-Rat
LD50 • 3500 mg/kg
Skin-Rabbit LD50 •17800 µL/kg

EU CLP: Annex VI, Table 3.1: Flam. Liq. 2, H225; AcuteTox. 4, H332; STOT RE 2, H373 (Ear, Inhl); Asp. Tox. 1,
H304
OSHA HCS 2012: Flam. Liq. 2; Acute Tox. 4 (Inhl); Eye
Irrit. 2; Carc. 2 (Inhl); Repr. 2 (Inhl); STOT SE 3: Narc.;
STOT SE 3: Resp. Irrit. (Inhl); STOT RE 2 (Ear, Inhl); Asp.
Tox. 1

Silicone
Polymers

Proprietary

15%
TO
25%

NDA

EU CLP: Not Classified
OSHA HCS 2012: Not Classified

NDA

TolueneCAS:108-88-3
EC
Number:203625-9
EU Index:601021-00-3< 1%

Ingestion/Oral-Rat
LD50 • 636 mg/kg
Skin-Rabbit LD50 •14100 µL/kg
Inhalation-Rat LC50 •49 g/m³ 4 Hour(s)EU CLP: Annex VI, Table 3.1: Flam. Liq. 2, H225; Skin
Irrit. 2, H315; Repr. 2, H361d; STOT SE 3: Narc., H336;
STOT RE 2, H373; Asp. Tox. 1, H304
OSHA HCS 2012: Flam. Liq. 2; Acute Tox. 4 (Orl); Skin
Irrit. 2; Eye Irrit. 2; Muta. 1B; Repr. 2; STOT SE 3: Narc.;
STOT RE 1 (CNS, Inhl); Asp. Tox. 1

NDA

See Section 16 for full text of H-statements.

Section 4 - First Aid Measures
4.1 Description of first aid measures
Inhalation

Skin
Eye
Ingestion• Move victim to fresh air. Administer oxygen if breathing is difficult. Give artificial
respiration if victim is not breathing. Do not use mouth-to-mouth method if victim
inhaled the substance; give artificial respiration with the aid of a pocket mask
equipped with a one-way valve or other proper respiratory medical device. Get medical
attention immediately.
• Wash skin with soap and water. Remove and isolate contaminated clothing. If irritation
develops and persists, get medical attention.
• In case of contact with substance, immediately flush eyes with running water for atleast 20 minutes. If eye irritation persists: Get medical advice/attention.
• Do NOT induce vomiting. Never give anything by mouth to an unconscious person.
Obtain medical attention immediately if ingested.

4.2 Most important symptoms and effects, both acute and delayed• Refer to Section 11 - Toxicological Information.

4.3 Indication of any immediate medical attention and special treatment needed
Notes to Physician• All treatments should be based on observed signs and symptoms of distress in thepatient. Consideration should be given to the possibility that overexposure to materials
other than this product may have occurred.

Section 5 - Firefighting Measures
Revision Date: March 2020
Page 4 of 13

Format: EU CLP/REACH Language: English (US)EU CLP, OSHA HCS 2012

Vacseal® II Vacuum Leak Sealant, Clear

5.1 Extinguishing media
Suitable Extinguishing Media • Water spray alcohol-resistant foam, Carbon dioxide Dry chemical.
Unsuitable ExtinguishingMedia• High volume water jet, or direct
stream of water.

5.2 Special hazards arising from the substance or mixture
Unusual Fire and Explosion
Hazards

Hazardous Combustion
Products• FLAMMABLE: Will be ignited by heat, sparks or flames. Containers may explodewhen heated.
Many liquids are lighter than water.
Vapors may form explosive mixtures with air.
Most vapors are heavier than air. They will spread along ground and collect in low or
confined areas (sewers, basements, tanks).
Vapors may travel to source of ignition and flash back.
Vapor explosion hazard indoors, outdoors or in sewers.
Runoff to sewer may create fire or explosion hazard.
• No data available

5.3 Advice for firefighters • Structural firefighters' protective clothing will only provide limited protection.

Wear positive pressure self-contained breathing apparatus (SCBA).
Move containers from fire area if you can do it without risk.
LARGE FIRES: Cool containers with flooding quantities of water until well after fire isout.

Section 6 - Accidental Release Measures
6.1 Personal precautions, protective equipment and emergency procedures
Personal Precautions•

Use appropriate Personal Protective Equipment (PPE)Emergency Procedures• Follow all safe handling advice.

6.2 Environmental precautions• Prevent entry into waterways, sewers, basements or confined areas.

6.3 Methods and material for containment and cleaning up
Containment/Clean-up
Measures• Contain and collect spill with absorbent materials wearing PPE. Place wet absorbent
material in container, close and contact local authorities for Haz-Mat waste disposal.
Use clean non-sparking tools to collect absorbed material.
A vapor suppressing foam may be used to reduce vapors.
All equipment used when handling the product must be grounded.

6.4 Reference to other sections• Refer to Section 8 - Exposure Controls/Personal Protection and Section 13 - Disposal
Considerations.

Section 7 - Handling and Storage
7.1 Precautions for safe handling
Handling• Use only in well ventilated areas. Keep away from heat, sparks, and flame. Do not use

Revision Date: March 2020
Page 5 of 13

Format: EU CLP/REACH Language: English (US)EU CLP, OSHA HCS 2012

Vacseal® II Vacuum Leak Sealant, Clear

sparking tools. Take precautionary measures against static charges. All equipmentused when handling the product must be grounded. Wear appropriate personal
protective equipment, avoid direct contact. Do not breathe mist, vapours and/or spray.
Avoid contact with skin, eyes, and clothing. Wash thoroughly with soap and water
after handling and before eating, drinking, or using tobacco.

7.2 Conditions for safe storage, including any incompatibilities
Storage• Store in a tightly closed container. Store in a cool, dry, well-ventilated place. Keepaway from heat, sparks, and flame.

7.3 Specific end use• This item is not being offered for clinical or diagnostic applications, agricultural uses orfor human or animal consumption. Refer to Section 1.2 - Relevant identified uses.

Section 8 - Exposure Controls/Personal Protection
8.1 Control parameters
Exposure Limits/Guidelines
Result

ACGIH

NIOSH

OSHA

Ceilings Not establishedNot established

300 ppm Ceiling

TWAs

20 ppm TWA

100 ppm TWA; 375 mg/m3 TWA

200 ppm TWA

STELs

Not established

150 ppm STEL; 560 mg/m3 STEL

Not established

Ethylbenzene(100-41-4)

TWAs

20 ppm TWA

100 ppm TWA; 435 mg/m3 TWA

100 ppm TWA; 435 mg/m3 TWA

STELs

Not established

125 ppm STEL; 545 mg/m3 STEL

Not established

Xylene(1330-20-7)

TWAs

100 ppm TWA

Not established

100 ppm TWA; 435 mg/m3 TWA

STELs

150 ppm STEL

Not establishedNot established

Toluene(108-88-3)

8.2 Exposure controls
Engineering
Measures/Controls• Good general ventilation should be used. Ventilation rates should be matched toconditions. If applicable, use process enclosures, local exhaust ventilation, or otherengineering controls to maintain airborne levels below recommended exposure limits.
If exposure limits have not been established, maintain airborne levels to an acceptablelevel. Use explosion-proof electrical/ventilating/lighting/equipment.
Personal Protective Equipment
Respiratory• Follow the OSHA respirator regulations found in 29 CFR 1910.134. Use a
NIOSH/MSHA approved respirator if exposure limits are exceeded or symptoms areexperienced.
Eye/Face• Wear chemical splash safety goggles.
Skin/Body• Wear appropriate gloves. Wear long sleeves and/or protective coveralls.
Environmental Exposure
Controls
Additional Protection
Measures• Controls should be engineered to prevent release to the environment, including
procedures to prevent spills, atmospheric release and release to waterways. Follow
best practice for site management and disposal of waste.
• An eyewash station and emergency shower must be available to the work station.

Key to abbreviations
ACGIH = American Conference of Governmental Industrial Hygiene

STEL = Short Term Exposure Limits are based on 15-minute exposures

NIOSH = National Institute of Occupational Safety and Health

TWA = Time-Weighted Averages are based on 8h/day, 40h/week exposures

OSHA = Occupational Safety and Health Administration

Section 9 - Physical and Chemical Properties
Revision Date: March 2020
Page 6 of 13

Format: EU CLP/REACH Language: English (US)EU CLP, OSHA HCS 2012

Vacseal® II Vacuum Leak Sealant, Clear

9.1 Information on Basic Physical and Chemical Properties
Material Description
Physical Form

LiquidAppearance/Description

Colorless to pale yellow liquid withsolvent odor.

Color

Colorless to pale yellow.

Odor

Solvent odor.

Odor Threshold

Data lacking

General Properties
Boiling Point> 100 °C(> 212 °F)

Melting Point/Freezing Point

Data lacking

Decomposition Temperature

Data lacking

pH

Data lacking

Water Solubility

Data lacking

Not explosive

Data lacking

Vapor Density

Data lacking

Specific Gravity/Relative Density

1.01 g/ml @ 25°C

Viscosity

125 Centistoke (cSt, cS) or
mm2/sec

Oxidizing Properties:

Data lacking

Volatility
Vapor Pressure

Data lacking

Evaporation Rate

Data lacking

Flammability
Flash Point

73.4 °F(23 °C) PMCC (PenskyMartins Closed Cup)

UEL

Data lacking

LEL

Data lacking

Autoignition

Data lacking

Flammability (solid, gas)

Data lacking

Environmental
Octanol/Water Partition coefficient

Data lacking

9.2 Other Information• No additional physical and chemical parameters noted.

Section 10: Stability and Reactivity
10.1 Reactivity• No dangerous reaction known under conditions of normal use.

10.2 Chemical stability• Stable under normal temperatures and pressures.

10.3 Possibility of hazardous reactions
10.4 Conditions to avoid• Hazardous polymerization will not occur.
• Keep away from heat, sparks and flame.

10.5 Incompatible materials• Oxidizing material can cause a reaction.

10.6 Hazardous decomposition products• Thermal breakdown of this product during fire of very high heat conditions may evolvethe following decomposition products: Carbon Oxides and traces of incompletely
burned carbon compounds, Silicon dioxide, Metal oxides, formaldehyde.

Section 11 - Toxicological Information
Revision Date: March 2020
Page 7 of 13

Format: EU CLP/REACH Language: English (US)EU CLP, OSHA HCS 2012

Vacseal® II Vacuum Leak Sealant, Clear

11.1 Information on toxicological effects
Components

Xylene (30%
TO 50%)

Acute Toxicity: Ingestion/Oral-Rat LD50 • 4300 mg/kg; Liver:Other changes; Kidney, Ureter, and Bladder:Otherchanges; Inhalation-Rat LC50 • 5000 ppm 4 Hour(s); Inhalation-Man LCLo • 10000 ppm 6 Hour(s); Behavioral:Generalanesthetic; Lungs, Thorax, or Respiration:Cyanosis; Blood:Other changes; Inhalation-Human TCLo • 200 ppm; Sense
Organs and Special Senses:Olfaction:Other changes; Sense Organs and Special Senses:Eye:Conjunctive irritation;
Lungs, Thorax, or Respiration:Other changes; Skin-Rabbit LD50 • >1700 mg/kg;
1330
Irritation: Eye-Rabbit • 5 mg 24 Hour(s) • Severe irritation; Skin-Rabbit • 500 mg 24 Hour(s) • Moderate irritation;-20Reproductive: Inhalation-Rabbit TCLo • 1 g/m³ 24 Hour(s)(7-20D preg); Reproductive Effects:Effects on
7
Fertility:Abortion; Inhalation-Rat TCLo • 50 mg/m³ 6 Hour(s)(1-21D preg); Reproductive Effects:Effects on Fertility:Postimplantation mortality; Reproductive Effects:Effects on Embryo or Fetus:Fetotoxicity (except death, e.g., stunted
fetus); Reproductive Effects:Specific Developmental Abnormalities:Craniofacial (including nose andtongue); Inhalation-Rat TDLo • 200 ppm 6 Hour(s)(4-20D preg); Reproductive Effects:Specific Developmental
Abnormalities:Musculoskeletal system; Reproductive Effects:Effects on Newborn:Behavioral

Acute Toxicity: Ingestion/Oral-Rat LD50 • 3500 mg/kg; Inhalation-Guinea Pig LCLo • 2500 ppm 8 Hour(s);Behavioral:Coma; Inhalation-Human TCLo • 21700 mg/m³; Behavioral:Antipsychotic; Inhalation-Mouse TCLo • 600 ppm 6
Minute(s); Lungs, Thorax, or Respiration:Respiratory depression; Skin-Rabbit LD50 • 17800 µL/kg;
Irritation: Eye-Rabbit • 500 mg • Severe irritation; Skin-Rabbit • 15 mg 24 Hour(s)-Open • Mild irritation;
Multi-dose Toxicity: Inhalation-Rat TCLo • 550 ppm 8 Hour(s) 5 Day(s)-Intermittent; Sense Organs and Special
Senses:Ear:Change in acuity; Sense Organs and Special Senses:Ear:Changes in cochlear structure orfunction; Inhalation-Rat TDLo • 200 ppm 13 Week(s)-Intermittent; Sense Organs and Special Senses:Ear:Changes incochlear structure or function;
Mutagen: Specific locus test • Intraperitoneal-Mouse • 754 µmol/L; Micronucleus test • Unreported Route-Hamster •Embryo (Somatic cell) • 25 mg/L; Sister chromatid exchange • Unreported Route-Human • Lymphocyte (Somatic cell) • 10
mmol/L; Mutation in Mammalian Somatic Cells • Unreported Route-Mouse • Lymphocyte (Somatic cell) • 80 mg/L;
Ethylbenzene 100Reproductive: Inhalation-Rabbit TCLo • 1 g/m³ 24 Hour(s)(7-20D preg); Reproductive Effects:Effects on(10% TO 30%) 41-4
Fertility:Abortion; Inhalation-Rat TCLo • 96 ppm 7 Hour(s)(1-19D preg); Reproductive Effects:Specific Developmental
Abnormalities:Musculoskeletal system; Inhalation-Rat TCLo • 1000 ppm (6-20D preg); Reproductive Effects:Effects on
Embryo or Fetus:Fetotoxicity (except death, e.g., stunted fetus); Inhalation-Rat TCLo • 600 mg/m³ 24 Hour(s)(7-15D
preg); Reproductive Effects:Effects on Fertility:Post-implantation mortality; Reproductive Effects:Effects on Embryoor Fetus:Fetal death; Reproductive Effects:Specific Developmental Abnormalities:Musculoskeletal system;
Tumorigen / Carcinogen: Inhalation-Mouse TCLo • 750 ppm 6 Hour(s) 2 Year(s)-Intermittent;
Tumorigenic:Carcinogenic by RTECS criteria; Lungs, Thorax, or Respiration:Bronchiogenic carcinoma;
Liver:Tumors; Inhalation-Rat TCLo • 750 ppm 6 Hour(s) 2 Year(s)-Intermittent; Tumorigenic:Carcinogenic by RTECS
criteria; Kidney, Ureter, and Bladder:Tumors; Inhalation-Rat TCLo • 23400 mg/kg 104 Week(s)-Intermittent;
Tumorigenic:Equivocal tumorigenic agent by RTECS criteria; Kidney, Ureter, and Bladder:Kidney tumors;
Reproductive Effects:Tumorigenic Effects:Testicular tumors
Acute Toxicity: Ingestion/Oral-Rat LD50 • 636 mg/kg; Inhalation-Rat LC50 • 49 g/m³ 4 Hour(s); Inhalation-Human TCLo •200 ppm; Brain and Coverings:Recordings from specific areas of CNS; Behavioral:Antipsychotic; Blood:Changes
in bone marrow not included above; Inhalation-Human TCLo • 1500 mg/m³ 8 Hour(s); Sense Organs and Special
Senses:Eye:Lacrimation; Sense Organs and Special Senses:Eye:Conjunctive irritation; Behavioral:Ataxia; Inhalation-Man TCLo • 50 ppm; Kidney, Ureter, and Bladder:Other changes in urine composition; Skin-Rabbit LD50 • 14100µL/kg;
Irritation: Eye-Rabbit • 2 mg 24 Hour(s) • Severe irritation; Skin-Rabbit • 20 mg 24 Hour(s) • Moderate irritation;
Multi-dose Toxicity: Inhalation-Mouse TCLo • 250 ppm 4 Day(s)-Continuous; Behavioral:Convulsions or effect on
108Toluene (< 1%)
seizure threshold; Behavioral:Abuse; Inhalation-Mouse TCLo • 50 ppm 12 Week(s)-Intermittent; Brain and
88-3
Coverings:Other degenerative changes; Inhalation-Rat TCLo • 10 ppm 6 Hour(s) 13 Week(s)-Intermittent; Brain and
Coverings:Other degenerative changes; Biochemical:Enzyme inhibition, induction, or change in blood or tissuelevels:Multiple enzyme effects;
Mutagen: Micronucleus test • Ingestion/Oral-Mouse • 200 mg/kg; Sister chromatid exchange • Inhalation-Human • 252µg/L 19 Year(s); Cytogenetic analysis • Inhalation-Rat • 5400 µg/m³ 16 Week(s)-Intermittent;
Reproductive: Inhalation-Mouse TCLo • 500 mg/m³ 24 Hour(s)(6-13D preg); Reproductive Effects:Effects on Embryo or
Fetus:Fetotoxicity (except death, e.g., stunted fetus); Inhalation-Mouse TCLo • 200 ppm 7 Hour(s)(7-16D preg);
Reproductive Effects:Specific Developmental Abnormalities:Urogenital system

GHS Properties

Classification
EU/CLP • Acute Toxicity - Dermal 4 - ATEmix (Derm) = 1650 mg/L ; Acute Toxicity -Revision Date: March 2020
Page 8 of 13

Format: EU CLP/REACH Language: English (US)EU CLP, OSHA HCS 2012

Vacseal® II Vacuum Leak Sealant, Clear

Acute toxicity

Inhalation 4 - ATEmix (Inhl, Vapors) = 11.9 mg/L 4h
OSHA HCS 2012 • Acute Toxicity - Inhalation 4 - ATEmix (Inhl, Vapors) = 11.9 mg/L 4h

Skin corrosion/Irritation

EU/CLP • Data lacking
OSHA HCS 2012 • Skin Irritation 2

Serious eye damage/Irritation

EU/CLP • Data lacking
OSHA HCS 2012 • Eye Irritation 2

Skin sensitization

EU/CLP • Data lacking
OSHA HCS 2012 • Data lacking

Respiratory sensitization

EU/CLP • Data lacking
OSHA HCS 2012 • Data lacking

Aspiration Hazard

EU/CLP • Aspiration 1
OSHA HCS 2012 • Aspiration 1

Carcinogenicity

EU/CLP • Data lacking
OSHA HCS 2012 • Carcinogenicity 2Germ Cell Mutagenicity

EU/CLP • Data lacking
OSHA HCS 2012 • Germ Cell Mutagenicity 1B

Toxicity for Reproduction

EU/CLP • Data lacking
OSHA HCS 2012 • Toxic to Reproduction 1B

STOT-SE

EU/CLP • Data lacking
OSHA HCS 2012 • Specific Target Organ Toxicity Single Exposure 3: Narcotic Effects;
Specific Target Organ Toxicity Single Exposure 3: Respiratory Tract Irritation

STOT-RE

EU/CLP • Specific Target Organ Toxicity Repeated Exposure 2
OSHA HCS 2012 • Specific Target Organ Toxicity Repeated Exposure 2

Potential Health Effects
Inhalation
Acute (Immediate)• Harmful if inhaled. May cause respiratory irritation. May affect the central nervous
system. Symptoms may include dizziness, drowsiness, lethargy, coma and death.
• Exposure to relatively low concentrations of ethylbenzene for several days to weeks
resulted in potentially irreversible damage to the inner ear and hearing of animals.

Chronic (Delayed)

Skin
Acute (Immediate)• Harmful in contact with skin. Causes skin irritation.
• No data available

Chronic (Delayed)

Eye
Acute (Immediate)• Causes serious eye irritation.
• No data available

Chronic (Delayed)

Ingestion
Acute (Immediate)• Material may be aspirated into lungs during ingestion and/or subsequent vomiting.
Aspiration of this material will cause severe lung injury, chemical pneumonitis,
pulmonary edema or death.
• No data available

Chronic (Delayed)
Mutagenic Effects• Repeated and prolonged exposure may cause mutagenic effects.
• Repeated and prolonged exposure may cause cancer.

Carcinogenic Effects

Carcinogenic Effects
CAS
Ethylbenzene

Reproductive Effects

100-41-4

IARC
Group 2B-Possible Carcinogen• Repeated and prolonged exposure may cause reproductive effects.

Revision Date: March 2020
Page 9 of 13

Format: EU CLP/REACH Language: English (US)EU CLP, OSHA HCS 2012

Vacseal® II Vacuum Leak Sealant, Clear

Key to abbreviations
LC = Lethal Concentration
LD = Lethal Dose
TC = Toxic Concentration
TD = Toxic Dose

Section 12 - Ecological Information
12.1 Toxicity• Material data lacking.

12.2 Persistence and degradability• Material data lacking.

12.3 Bioaccumulative potential• Material data lacking.

12.4 Mobility in Soil
• Material data lacking.

12.5 Results of PBT and vPvB assessment• No PBT and vPvB assessment has been conducted.

12.6 Other adverse effects• No studies have been found.

Section 13 - Disposal Considerations
13.1 Waste treatment methods
Product waste
Packaging waste• Dispose of content and/or container in accordance with local, regional, national, and/orinternational regulations.
• Dispose of content and/or container in accordance with local, regional, national, and/orinternational regulations.

Section 14 - Transport Information
14.1 UN
number

14.2 UN proper
shipping name14.3 Transport hazard
class(es)14.4 Packing
group

14.5 Environmental
hazards

DOT

UN 1993

Flammable liquids

3

III

NDA

IMO/IMDG

UN1866

Flammable liquids

3

III

NDA

IATA/ICAO

UN1866

Flammable liquids

3

III

NDA

14.6 Special precautions foruser
14.7 Transport in bulk
according to Annex II of
Marpol and the IBC Code• None specified.
• Data lacking.

Section 15 - Regulatory Information
Revision Date: 2020
Page 10 of 13

Format: EU CLP/REACH Language: English (US)EU CLP, OSHA HCS 2012

Vacseal® II Vacuum Leak Sealant, Clear

15.1 Safety, health and environmental regulations/legislation specific for the substance or
mixtureSARA Hazard Classifications • Acute, Chronic, Fire
Inventory
Component

CAS

Canada DSL

Canada NDSLEU EINECS

EU ELNICS

TSCA

Ethylbenzene

100-41-4

Yes

No

Yes

No

Yes

Toluene108-88-3

Yes

No

Yes

No

Yes

Xylene1330-20-7

Yes

No

Yes

No

Yes

CanadaLabor
Canada - WHMIS 1988 - Classifications of Substances• Ethylbenzene• Toluene• Xylene

100-41-4
108-88-3
1330-20-7

B2, D2A, D2B
B2, D2A, D2B
B2, D2A, D2B

Canada - WHMIS 1988 - Ingredient Disclosure List
• Ethylbenzene• Toluene• Xylene

100-41-4
108-88-3
1330-20-7

0.1 %
1%
Not Listed

Canada - CEPA - Priority Substances List
• Ethylbenzene

100-41-4• Toluene108-88-3• Xylene

1330-20-7

Not Listed
Priority Substance List 1(substance not considered
toxic)
Priority Substance List 1(substance not considered
toxic)

Environment

United States
Labor

U.S. - OSHA - Process Safety Management - Highly Hazardous Chemicals• Ethylbenzene• Toluene• Xylene

100-41-4
108-88-3
1330-20-7

Not Listed
Not Listed
Not Listed

U.S. - OSHA - Specifically Regulated Chemicals• Ethylbenzene• Toluene• Xylene

100-41-4
108-88-3
1330-20-7

Not Listed
Not Listed
Not Listed

100-41-4
108-88-3
1330-20-7(listed under Ethyl benzene)

Environment
U.S. - CAA (Clean Air Act) - 1990 Hazardous Air Pollutants• Ethylbenzene• Toluene• Xylene(isomers and mixtures)

U.S. - CERCLA/SARA - Hazardous Substances and their Reportable Quantities• Ethylbenzene

100-41-4

Revision Date: March 2020
Page 11 of 131000 lb final RQ; 454 kg final
RQ

Format: EU CLP/REACH Language: English (US)EU CLP, OSHA HCS 2012

Vacseal® II Vacuum Leak Sealant, Clear

1000 lb final RQ; 454 kg final
RQ
100 lb final RQ; 45.4 kg final
RQ• Toluene108-88-3• Xylene

1330-20-7

U.S. - CERCLA/SARA - Radionuclides and Their Reportable Quantities• Ethylbenzene• Toluene• Xylene

100-41-4
108-88-3
1330-20-7

Not Listed
Not Listed
Not Listed

U.S. - CERCLA/SARA - Section 302 Extremely Hazardous Substances EPCRA RQs• Ethylbenzene• Toluene• Xylene

100-41-4
108-88-3
1330-20-7

Not Listed
Not Listed
Not Listed

U.S. - CERCLA/SARA - Section 302 Extremely Hazardous Substances TPQs
• Ethylbenzene• Toluene• Xylene

100-41-4
108-88-3
1330-20-7

Not Listed
Not Listed
Not Listed

U.S. - CERCLA/SARA - Section 313 - Emission Reporting
0.1 % de minimis
concentration
1.0 % de minimis
concentration
1.0 % de minimis
concentration• Ethylbenzene

100-41-4• Toluene108-88-3• Xylene

1330-20-7

U.S. - CERCLA/SARA - Section 313 - PBT Chemical Listing• Ethylbenzene• Toluene• Xylene

100-41-4
108-88-3
1330-20-7

Not Listed
Not Listed
Not Listed

U.S. - California - Proposition 65 - Carcinogens List
• Ethylbenzene• Toluene• Xylene

100-41-4
108-88-3
1330-20-7

carcinogen, 6/11/2004
Not Listed
Not Listed

U.S. - California - Proposition 65 - Developmental Toxicity• Ethylbenzene

100-41-4• Toluene108-88-3• Xylene

1330-20-7

Not Listeddevelopmental toxicity,
1/1/1991
Not Listed

U.S. - California - Proposition 65 - Maximum Allowable Dose Levels (MADL)• Ethylbenzene

100-41-4• Toluene108-88-3• Xylene

1330-20-7

United States - California
Environment

Not Listed
7000 µg/day MADL (level
represents absorbed dose)
Not Listed

U.S. - California - Proposition 65 - No Significant Risk Levels (NSRL)• Ethylbenzene

100-41-4• Toluene108-88-3

Revision Date: 2020
Page 12 of 13

54 µg/day NSRL (inhalation);
41 µg/day NSRL (oral)
Not Listed

Format: EU CLP/REACH Language: English (US)EU CLP, OSHA HCS 2012

Vacseal® II Vacuum Leak Sealant, Clear• Xylene

1330-20-7

Not Listed

U.S. - California - Proposition 65 - Reproductive Toxicity - Female• Ethylbenzene• Toluene• Xylene

100-41-4
108-88-3
1330-20-7

Not Listed
Not Listed
Not Listed

U.S. - California - Proposition 65 - Reproductive Toxicity - Male• Ethylbenzene• Toluene• Xylene

100-41-4
108-88-3
1330-20-7

Not Listed
Not Listed
Not Listed

15.2 Chemical Safety Assessment• No Chemical Safety Assessment has been carried out.

15.3 Other Information• WARNING: This product contains a chemical known to the State of California tocause cancer, birth defects or other reproductive harm.

Section 16 - Other Information
Relevant Phrases (code & full text)• H226 - Flammable liquid and vapor
H315 - Causes skin irritation
H336 - May cause drowsiness or dizziness
H361d - Suspected of damaging the unborn child.
Revision Date
• 27/March/2020
Preparation Date

• 15/January/2014

Disclaimer/Statement of
Liability• The information stated in this Safety Data Sheet is designed only as guidance for safe
handling, use, storage, transportation, and disposal. This product should be used onlyin the context of its intended manner of use and include proper assessment of theappropriateness by the end user. The information relates only to the specific material
designated and may not be valid when used in combination with any other materials orif this product has been repackaged, renamed or relabeled. The information provided
in this Safety Data Sheet is correct to the best of our knowledge, information and belief
at the date of its publication or revisions.

Revision Date: March 2020
Page 13 of 13

Format: EU CLP/REACH Language: English (US)EU CLP, OSHA HCS 2012